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This study was carried out to understand the perceptions and expectations of the other health care 
professionals about pharmacists’ role in primary health care centers and hospitals in Santiago de Cuba 
(Cuba). A cross-sectional descriptive study was conducted, applying a self-administered questionnaire 
to health care professionals. The sample included 763 professionals (40.9% physicians and 59.1 % 
nurses) from hospitals and primary health care clinics, chosen by random stratified sampling,. The most 
common activity performed by pharmacists was the distribution of medications or the drug supply 
management (51.5%) and adverse drug reactions reporting (29.4%), activities performed daily by 
pharmacists. Pharmaceutical care practice was considered as poor by the professionals, and only 15.6% 
of them have collaborated in these programs in the past. For nurses and physicians, interprofessional 
communication occurs sometimes (56.9%) and never (25.8%). Pharmacists’ integration into the health 
team was considered as fair (50.7%). A total of 70.1% perceived the pharmacist as a drug expert and 
60.1% as a professional who provides medication counseling. The main expectations these health care 
professionals expressed were that pharmacists provide more education about medication (97.4%) and 
improve their interprofessional communication techniques in order to communicate more effectively 
with the other members of the health care team (96.6%). 
Uniterms: Pharmacists/professional functions. Pharmaceutical care. Interprofessional communication.
O presente trabalho analisa o papel do farmacêutico na atenção primária de saúde e em hospitais, na 
percepção de profissionais da saúde na província de Santiago de Cuba. Um estudo descritivo transversal 
foi conduzido, através da aplicação de um questionário autoadministrado a uma amostra de 763 
profissionais de atenção primária e hospitalar, 40,9% de médicos e 59,1% de enfermeiros. As funções 
farmacêuticas mais reconhecidas pelos profissionais desta amostra foram o fornecimento e distribuição de 
medicamentos (51,5%) e o relato de reações adversas medicamentosas (29,4%), funções desenvolvidas 
diariamente. A prática da atenção farmacêutica é limitada na percepção dos profissionais e apenas 15,6% 
têm participado em programas desse tipo. Comunicação interprofissional ocorre às vezes (56,9%) e 
nunca (25,8%), com maiores dificuldades na atenção primária de saúde. A integração do farmacêutico 
na equipe de saúde foi considerada regular (50,7%). Um total de 70,1% dos profissionais percebeu o 
farmacêutico como especialista em medicamentos e 64,1% como o profissional que aconselha sobre 
o uso de medicamentos. As principais expectativas colocam-se na necessidade de que o farmacêutico 
ofereça educação sobre o uso de medicamentos (97,4%) e reforce as suas técnicas da comunicação na 
equipe multidisciplinar (96,6%).
Unitermos: Farmacêutico/funções profissionais. Atenção farmacêutica. Comunicação interprofissional.
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INTRODUCTION
Professions exist to serve society. Therefore, the 
mission of the pharmacy profession must be to address 
the drug-related needs of society and individual patients. 
(Hepler, 1985).
Over the past 40 years, the pharmacist’s role has 
been changing from that of compounder and dispenser 
of medicines to one of “drug therapy manager” (World 
Health Organization, International Pharmaceutical Federa-
tion, 2006). In the 21st century, the pharmacy profession 
continues to move toward a patient-centered practice 
(Ramalho de Oliveira, Shoemaker, 2006). This profes-
sional practice model or new approach to patient care 
is being called pharmaceutical care, medication therapy 
management or cognitive services, and represents a major 
transformation in the social responsibility of pharmacists. 
It is a paradigmatic change that redefines the identity of the 
pharmacist as a health care provider which has the patient 
as the focus of practice (Ramalho de Oliveira, 2009).
In the health care field, it is expected and assumed that 
physicians, pharmacists, nurses and others professionals 
make clinical decisions anchored in a strong ethical perspec-
tive (Martínez, Baena, 2001). Also, there is an increasing 
interest among health care professionals to optimize patient 
care by applying a teamwork approach (Florentinus et al., 
2006). The World Health Professions Alliance was estab-
lished in 1999 to facilitate close collaboration between the 
International Pharmaceutical Federation (FIP), the World 
Medical Association (WMA), the International Council 
of Nurses (ICN), and the World Dental Federation (FDI) 
in support of governments, policy-makers, and the World 
Health Organization (WHO) with the purpose of delivering 
higher quality and more cost-effective health care world-
wide (www.whpa.org). Through this alliance, over 20 mil-
lion health care professionals can be reached worldwide, 
providing a valuable source of knowledge and experience.
The health care team consists of the patient and all 
the health care professionals who have responsibility for 
patient care. This team needs to be well defined, and col-
laboration needs to be actively sought. It is believed that 
pharmacists have an important role to play in this team. 
However, they will need to adapt their knowledge, skills 
and attitudes to this new role, which integrates traditional 
pharmaceutical science knowledge with clinical aspects 
of patient care, namely clinical, management and commu-
nication skills, ability to actively collaborate with medical 
teams, and competence to prevent and resolve medicine-
related problems (WHO, IPF, 2006).
It should be highlighted that the practice of pharma-
ceutical care does not exist and should not exist in isolation 
from other health care services. It must be provided in 
collaboration with patients, physicians, nurses, and other 
health care providers. The pharmaceutical care practitioner 
develops a partnership with the patient and other providers 
in order to ensure patients get the most benefit from all 
their medications (Dupotey, Ramalho de Oliveira, 2009).
The Cuban Health System has a remarkable repu-
tation in the public health services, showing excellent 
indicators in Latin America, almost comparable with 
those of developing countries worldwide. However, 
pharmaceutical care practice has not yet been developed 
by pharmacists in their daily practice. Despite the fact that 
this practice model was introduced in Cuban pharmaceuti-
cal policies in 2005, through the handbook “Norms and 
Proceedings’ for Community and Hospital Pharmacies” 
(Cuban Ministry of Public Health, 2005; Cuban Ministry 
of Public Health, 2006; Medication National Program, 
2007), there are some implementation barriers to pharma-
ceutical care, which must be investigated and overcome 
so that this practice can be developed and systematically 
available throughout the entire Cuban health care system.
One of the premises of the philosophy of pharma-
ceutical care is that the patient should be at the center of 
the practice and be seen as a teacher who can teach the 
pharmacist about the meanings of being ill and of using 
medications. As Ramalho de Oliveira and Shoemaker 
(2006) wrote: “…Members of the profession must be 
open to learn with and from the patient and develop 
a holistic comprehension of patients’ understandings, 
beliefs, attitudes, and behaviors toward health, disease, 
and medications.” We would like to go beyond this as-
sertion to underscore that, besides being open to patients, 
pharmacists should also tend to the expectations and 
perceptions of other health care providers because, in 
order to care holistically and effectively for patients, 
pharmacists must collaborate with other professionals in 
the community and hospitals. This can also be considered 
a piece of the humanistic component and of the psycho-
social aspects associated with pharmaceutical care prac-
tice. In this regard, in recent years, several studies have 
explored interprofessional perspectives of pharmacists’ 
role, which have gained an increased prominence in the 
pharmacy literature.
Some of the most recent studies include the analysis 
of physicians’ perceptions of pharmacists’ provision of 
medication therapy management services to outpatients 
in Chicago, United States (Padiyara, Rabi, 2006), doc-
tors’ and nurses’ perceptions of pharmacists’ activities 
in university teaching hospitals in Nigeria (Olubunmi, 
Oyedepo, Erhun, 2009), and pharmacists’ contributions 
to basic health care from the perspectives of professionals 
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of the familial health care teams in Santa Catarina, Brazil 
(Loch-Neckel, Crepaldi, 2009), etc.
In fact, nowadays, the knowledge of the meanings 
of pharmacists’ work and roles by physicians and nurses 
acquires a special significance in the exploration of the sta-
tus of pharmacy practice. These perspectives can assist the 
profession to better understand pharmacists’ situation in 
the health care system so that it can be enhanced, changed 
and advanced to better meet our patients’ drug-related 
needs. This study was conducted in response to this social 
need. Its goal was to reveal pharmacists’ roles in the health 
care system through the eyes of physicians and nurses in 
community and hospital settings in Santiago de Cuba.
METHODS
Study characteristics, setting, sample and ethical 
considerations
This was a descriptive and cross-sectional study, 
carried out during the months of February, March, and 
April of 2007 and 2008. The sample included 763 profes-
sionals, 361 from hospitals and 402 from primary health 
care clinics in Santiago de Cuba City. More specifically, 
this study included physicians and nurses who work at 12 
hospitals in several municipalities (Santiago de Cuba, San 
Luis, Songo La Maya, Palma Soriano, and Contramaestre) 
and at some primary health clinics located in the surround-
ings of the Principal Municipal Pharmacy of Santiago de 
Cuba, which includes 4 districts. For the hospital settings, 
the sample size was calculated from a finite population of 
5,960 professionals, and for primary health care services 
the sample size was calculated considering an unknown 
population size (this information was not accessible to 
the research team). The samples were chosen by stratified 
random sampling, with a 95% of confidence level.
The research project was approved by the Institu-
tional Review Board/Research Committee of the Depart-
ment of Pharmacy, Faculty of Natural Sciences of The 
Oriente University, Santiago de Cuba, Cuba. All partici-
pants were clarified about the objectives and methods of 
the study by means of reading and explaining the informed 
consent form and having it signed. This research did not 
present risks for its participants; they were assured about 
confidentiality and received reassurance that the results 
will be shared with them.
Variables, instruments and procedures to analysis
The data was collected through a self-administered 
questionnaire by the professionals. Before its application, 
this instrument was analyzed by 10 experts and tested for 
validation with 160 practicing community and hospital 
professionals, who accepted to collaborate with the proj-
ect. Therefore, the final questionnaire was formulated 
based on the comments of experts and professionals, and 
included five topics:
·	 Sample characterization: professional or technical 
qualification; years of experience; and health care 
settings where they work.
·	 Activities performed by pharmacists in a health care 
team, based on doctors’ and nurses’ experiences. The 
frequency of execution of the following professional 
activities was considered: participation in rounds at 
hospital; suggestions to optimize prescriptions and 
administration of medications; provision of drug 
information; detection and reporting of adverse drug 
reactions; drug supply management; drug education; 
teaching; and research. 
·	 Physicians’ and nurses’ participation in pharmaceu-
tical care programs developed by pharmacists, and 
their collaboration in the prevention and solution 
of negative results associated with drug therapy (A 
Third Spanish Consensus of Pharmaceutical Care 
was used as reference). (Granada’s Research Group, 
2007)
·	 Interprofessional relationship, communication 
and barriers perceived. The interprofessional re-
lationship was categorized into four categories: 
excellent, good, fair, and bad. The frequency of 
communication between these professionals was 
also obtained. In the case of unsatisfactory respon-
ses, the main barriers were identified.
·	 Perceptions and expectations of pharmacists’ role 
as a health care professional, including the respon-
sibilities on patients’ medication therapy and the 
interaction with the health team.
Descriptive statistics was used to characterize the 
professionals’ samples. All data were analyzed establish-
ing a comparison between health care settings and the 
professionals’ qualifications, through a non-parametric c2 
(chi square), method of contingency tables, with a level of 
significance α=0.05. 
RESULTS AND DISCUSSION
The questionnaire was completed by 763 health care 
professionals, being 40.9% physicians and 51.9% nurses. 
A total of 47.3% of the professionals worked at hospitals 
and 52.7% at primary health care services. The mean of 
years of professional experience was 12.6 years. From 
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physicians’ and nurses’ perspectives, the most common 
activities carried out by pharmacists were drug supply 
management (70.4%) and detection and reporting of ad-
verse drug reactions (51.1%). Table I shows the frequen-
cies of professionals’ perceptions of the various activities 
performed by pharmacists in different health care settings.
In general, there is a low perception about the per-
formance of clinical functions of pharmacists, as these ac-
tivities appear in the lowest frequencies of physicians’ and 
nurses’ perspectives. Significant differences were found 
in health care settings, and pharmacists’ clinical activities 
in community pharmacists and other primary care settings 
had the lowest frequencies. The pharmacist’s participation 
in hospital rounds does not occur from the perspective of 
83.9% of professionals from this setting.
Education on drug use, health promotion, disease 
prevention and lifestyle modification are activities usually 
performed at the community level and that have a public 
health focus. In this case, as shown, these functions are 
performed monthly, generally in the primary care settings 
(43.8%).
In hospitals, a daily review of patients’ prescriptions 
by a pharmacist is necessary. It is well known that most 
of the drug-related morbidity and mortality in this setting 
is predictable and can be avoided, which would reduce 
the duration of hospitalization and, consequently, the 
overall cost of health care, while improving the quality 
of care (Traynor, 2009; Abdel-Qader, Harper, Cantrill, 
Tully, 2010).
However, this daily expected pharmacist interven-
tion is not observed by the majority of the participants in 
this study. A study that examined medical practitioner’s 
experiences with the role of hospital-based pharmacists 
in Sudan shows similar results. One half of respondents 
never or rarely had interactions with pharmacists with re-
gard to their patients’ medications, 36.9% and 13.1% had 
this type of contact once per week or once a day or more, 
respectively. (Awad, Matow, Capps, 2007).
In this study, only 15.6% of professionals had been 
contacted to participate in pharmaceutical care programs, 
generally by community pharmacists. Only 12 profes-
sionals participated in pharmaceutical care programs in 
hospitals. These differences were significant. Regarding 
professional qualification, only 13.1% of physicians and 
8.4% of nurses recognized to participate in these programs. 
Collaboration with pharmacists in preventing and resolv-
ing negative outcomes associated with medication was low 
(17.7%), and the most common problems were: untreated 
health problem (82.2%), quantitative ineffectiveness 
(80.7%), and non-quantitative ineffectiveness (78.5%).
Pharmacists collaborate in the education of phar-
macy students in 27.6%, and conduct drug research with 
TABLE I - Participants’ perceptions of activities carried out by pharmacists in health care teams in different settings
Pharmacists’ functions
Frequencies 
Primary health care (PHC) n = 402/ Hospital (H)n = 361 / Total 763 
Number of professionals - n  
(Percentage) (%)
Daily Weekly Monthly Not performed
p value
PHC H PHC H PHC H PHC H
Patient care rounds at 
hospital
 - 14 (3.9)  - 19 (5.3) - 25 (6.9) - 303 (83.9) -
Suggestions to optimize 
drug prescriptions and 
administration
16 (4.0) 84 (24.1) 99 (24.6) 52 (14.4) 167 (41.5) 70 (19.4) 120 (29.8) 152 (42.1) p=0.000
Detection and reporting 
of drug adverse reactions
32 (8.0) 192 (53.2) 135 (33.6) 31 (8.6) 134 (33,3) 50 (13.9) 99 (24.6) 88 (24.4) p=0.000
Drug supply 
management and 
dispensation 
88 (21.9) 305 (84.5) 113 (28.1) 12 (3.3) 128 (31.8) 11 (3.0) 73 (18.1) 33 (9.14) p=0.000
Drug information to 
health care professionals
27 (6.7) 110 (30.5) 129 (32.1) 68 (18.8) 149 (37.1) 78 (21.6) 97 (24.1) 105 (29.1) p=0.000
Drug education and 
health promotion 
activities
20 (5.0) 58 (16.1) 112 (27.9) 73 (20.2) 176 (43.8) 75 (20.8) 94 (23.4) 155 (42.9) p=0.000
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Legends: Ph. C: Participation in pharmaceutical care programs; 
Non Ph. C: Non participation in pharmaceutical care programs; 
PHC: Primary health care H: Hospital
FIGURE 1 - Professionals’ participation in pharmaceutical care 
programs. p = 0.001
a health care team in 33%; in this last case, there was not 
a statistical difference between the different health care 
settings. 
Another study, conducted by Penaforte, Forste, and 
Simões in Ribeirão Preto, Brazil, assessed the practices of 
pharmacists in a hospital setting. A structured instrument 
was applied and the following five areas were analyzed: 
sector management, hospital compounding, committee 
activities, information and pharmacotherapeutic follow-
up, as well as teaching and research activities. They found 
that some essential services such as drug information 
service and pharmacotherapeutic follow-up were absent 
(Penaforte, Forste, Simões, 2007). These results illustrate 
how pharmacists’ practice is still focused on drugs and 
not on patients. Precisely, these clinical functions, which 
have the potential to encourage the social recognition of 
pharmacists, are rarely carried out, both from physicians’ 
and nurses’ perspectives.
Similar findings were found in a previous study 
performed to characterize the professional practice of 
pharmacists in Santiago de Cuba, from their own points 
of view. In this research, the most frequent activities 
observed were administrative functions and dispensing. 
(Martínez, Dupotey, Brea, 1999). It is troublesome that 
this is still the reality today. Pharmaceutical care practice 
is scarce and not systematic in Cuba. The analysis of Cu-
ban pharmacists’ contexts of practice could explain this 
phenomenon. There are no legislation or pharmaceutical 
policies regulating the provision of pharmaceutical care 
services. Pharmacists’ activities are regulated by the Na-
tional Direction of Pharmacy, through the “Norms and 
Proceedings for Community and Hospital Pharmacies”. 
This document presents gaps and misconceptions about 
the definition of pharmaceutical care, its implementation 
and evaluation, according to the most recent and basic 
understandings of this practice model. (Cipolle, Strand, 
Morley, 2004; Comité de Consenso de Granada, 2007; 
Ramalho de Oliveira, 2010). On the other hand, there is a 
document that regulates the legal functions of pharmacists 
in Cuba, called “Qualifier of Charges for Pharmacists” 
(Cuban Ministry of Public Health, 2005), which states a 
list of many different functions that should be carried out 
by pharmacists and are completely disconnected from the 
reality of a clinical practice model such as pharmaceuti-
cal care. Furthermore, these activities have no connection 
to a social need and to the requirements described in the 
“Norms and Proceedings for Community and Hospital 
Pharmacies.”
On the other hand, pharmaceutical care in Cuba is 
usually developed at experimental level, not at practice 
level. There are structural aspects under analysis that limit 
the development and delivery of services such as pharma-
cotherapy follow-up. For instance, many pharmacies do 
not have a private room for patients’ consultations; more-
over, they have a small number of pharmacists dedicated 
to clinical functions and a large number of pharmacists 
performing several functions at the same time. The Mu-
nicipal Pharmacy, which is the main community pharmacy 
of the territory and controls the activities that take place 
in all the other pharmacies, is the only pharmacy that has 
a clinical pharmacist in its staff as a legal determination. 
In the other community and hospital pharmacies, this 
function is expected from the pharmacist in response to a 
specific situation or a requirement of the boss.
The pharmacists’ integration with the health care 
team was considered by physicians and nurses as fair 
(50.7%), good (32.1%), bad (15.5%), and excellent (only 
2.1%). Significant differences in the health care settings 
were found (p=0.018). In a hospital environment, pharma-
cists are more integrated with the health care team. There 
was a large number of pharmacists who perform clinical 
functions daily in hospitals.
In the hospital setting, pharmacists have an excellent 
opportunity to interact with patients, to access patients’ 
clinical records (including medication therapies), and to 
have more interaction with physicians and nurses, which 
permit the establishment of common strategies to optimize 
patients’ medication therapies. Hospital pharmacy has led 
the way to expand the role of pharmacy technicians so that 
pharmacists can have a bigger role in direct patient care 
(Royal Pharmaceutical Society of Great Britain, 2006).
In the hospital setting, pharmacists may participate 
in patient care rounds with physicians and other health 
care providers, counsel patients, and offer information/
education to other health care providers. Pharmacists 
participate in key committees at these institutions, includ-
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ing the Pharmacy and Therapeutics Committee, antibiotic 
monitoring committees, and medication safety commit-
tees. Pharmacists also practice in many other settings such 
as ambulatory care clinics, managed care, and long-term 
care, and partici pate in a number of pharmaceutical ser-
vices (Zeind, Mc Closkey, 2006).
Table II shows the barriers identified by participants 
with regard to establishing professional relationships.
The most important barriers perceived by profes-
sionals in establishing a relationship with pharmacists 
were: “I don’t know who the pharmacist is” (37.6%); “The 
pharmacist has not contacted me” (36.0%); lack of time 
of physicians and nurses (33.4%); and lack of time of the 
pharmacist (33.4%). These findings suggest a low level of 
communication between health providers and pharmacists, 
which is corroborated by the frequencies perceived by the 
professionals (always-=17.3%, sometimes=56.9% and 
never=25.8%).
Statistical differences were found in health settings 
and professional qualification. Specifically, in primary 
health care clinics, the professionals considered the lack 
of pharmacists’ time as the main barrier to the relationship 
(65.4%). In the hospital setting, professionals did not know 
who the pharmacist is (48.8%). Regarding professional 
qualification, 34.6% of physicians believe that lack of 
pharmacist’s time is the main barrier and 41.7% of nurses 
do not know who the pharmacist is.
Ethical issues in interprofessional communication 
appear in 15.7% of responses, being 27.0% in primary 
care and 13.3% in the hospital setting. Many barriers 
have been mentioned by different authors. Communica-
tion troubles and lack of time of pharmacists and of other 
health providers have been found in studies that explored 
facilitators (Gastelurrutia et al., 2009) and barriers to 
pharmacotherapy follow-up (Hidalgo et al., 2005), and 
the implementation of pharmaceutical care services (Uema 
et al., 2008). A research study performed by the Pharma-
ceutical Care Network Europe compiled and structured 
into domains a list of 25 barriers, identified by structured 
interviews with pharmacists from 11 European countries. 
The barriers were compiled in five domains: resources, 
attitudes and opinions, education, skills, and environ-
ment. According to the interviewees, the lack of time, 
the attitude/opinion of other professionals and the lack of 
communication skills were the major barriers perceived 
in all participant countries (Foop, 2000).
Insufficient communication between pharmacists 
and physicians occurs for several reasons. One barrier that 
has been cited is pharmacists’ expressed lack of confidence 
in their ability to persuade physicians to accept their rec-
ommendations. Another possible cause is ineffective or 
needless communication initiated by pharmacists, which 
makes physicians less willing to listen to pharmacists dur-
ing future interactions (Ranelli, Biss, 2000). With commu-
nication so limited, physicians are unable to benefit from 
a pharmacist’s suggestion about drug therapy.
Respondents’ perceptions of pharmacists are shown 
in Table III. The most common perceptions were: the phar-
macist is a drug expert (70.1%), the pharmacist counsels 
patients about their drugs (64.1%), and the pharmacist ex-
clusively supplies, controls and dispenses drugs (61.3%).
Similarly, significant differences in health care set-
tings and physicians’ and nurses’ perceptions were found. 
Fifty percent of professionals of primary health care 
consider the pharmacist as someone who counsels about 
the use of drugs, and 96.7% of hospital health providers 
consider the pharmacist as someone who exclusively 
delivers, controls and dispenses drugs. The professionals 
TABLE II - Barriers to interprofessional relationship perceived by participants
Barriers
Primary health care Hospital
Phys. (%) Nurs. (%) Total (%) Phys. (%) Nurs. (%) Total (%)
Lack of pharmacist’s time 91 (52.3) 83 (47.7) 174 (65.2) 17 (21.0) 64 (79.0) 81 (22.4)
I don’t know who the pharmacist is 50 (45.1) 61 (54.9) 111 (41.6) 49 (27.8) 127 (72.2) 176 (48.8)
Lack of time of physician or nurse 77 (55.0) 63 (45.0) 140 (52.4) 21 (17.4) 100 (82.6) 121 (33.5)
Underutilization of pharmacist as a 
medication expert
44 (59.4) 40 (52.3) 74 (27.7) 8 (47.1) 9 (52.9) 17 (4.7)
I don’t trust the pharmacist 33 (50.0) 33 (50.0) 66 (24.7) 1 (14.3) 6 (85.7) 7 (1.9)
The pharmacist has not contacted me 60 (45.1) 73 (54.9) 133 (49.8) 42 (29.6) 100 (70.4) 142 (39.3)
Ethical troubles in interprofessional 
communication
33 (45.8) 39 (54.2) 72 (27.0) 8 (16.7) 40 (83.3) 48 (13.3)
Phys. Physicians; Nurs. Nurses; pa= 0.000 - Probability calculated according to health care settings; pb= 0.033- Probability calculated 
according to professional qualification
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TABLE III - Professional’s perceptions of pharmacists’s role
Professionals’ perceptions of 
pharmacists 
Primary health Care Hospital
Phys. (%) Nurs. (%) Total (%) Phys. (%) Nurs. (%) Total (%)
Professional expert on drugs 92 (47.2) 103 (52.8) 195 (48.5) 94 (27.7) 246 (72.3) 340 (94.2)
Counsels on the use of drugs 105 (52.2) 96 (47.8) 201 (50.0) 81 (28.1) 207 (71.9) 288 (79.8)
Exclusively supplies, controls and 
dispenses drugs
50 (42.0) 69 (58.0) 119 (29.6) 93 (26.7) 256 (73.4) 349 (96.7)
Responsible for the drug problems 
of the patients
11 (55.0) 9 (45.0) 20 (5.6) 44 (28.2) 112 (71.8) 156 (43.2)
The physician’ and nurse’ partner 
in the decision-making process on 
medications
78 (83.0) 16 (17.0) 94 (23.4) 49 (33.5) 117 (66.5) 166 (46.0)
pa= 0.000 - Probability calculated according to health care settings; pb= 0.000- Probability calculated according to professional 
qualification
recognized the expertise of pharmacists in pharmaco-
therapy according to their competence and knowledge 
area. Moreover, the functions most often perceived by 
professionals are associated with their perceptions. 
Particularly, physicians perceive pharmacists as drug 
experts and as counselors in equal proportion (59.6%). The 
nurses perceive the pharmacist as a drug expert (77.3%) 
and as someone who exclusively supplies drugs (72.1%). 
In fact, the relationship between pharmacists and nurses 
in drug supply functions can be considered a response to 
these limited perceptions.
Ranelli and Biss (2000) studied physicians’ per-
ceptions of communication with and responsibilities of 
pharmacists. Structured interviews and a survey mailed 
to a convenience sample of physicians were conducted. 
Respondents were most comfortable with pharmacists’ 
responsibilities of identifying prescription errors (88.0%), 
providing patient education (65.1%), suggesting nonpre-
scription medications (63.4%), and suggesting prescrip-
tion medications to physicians (52.0%). For 79.2% of 
respondents, an office nurse had the most contact with 
pharmacists.
Harriman et al. (2010) identified physicians’ percep-
tions of community pharmacists’ provision of medication 
therapy management through a qualitative analysis. The 
need for a trusting relationship between a patient’s primary 
care physician and the pharmacist providing medication 
therapy management was identified.
Similarly, Olubunmi, Oyedepo and Erhun (2009) 
examined the attitudes of 90 doctors and 160 nurses to-
wards pharmacists’ activities in three university teaching 
hospitals in Southwestern Nigeria. The activities were 
grouped into four domains: the pharmacist’s influence on 
prescribing and medicine use, dispensing of prescription 
medications, participation in health promotion, and drug 
supply management. Dispensing functions ranked high-
est, while medicine supply activities were rated lowest in 
importance. Both groups rated pharmacists’ performance 
lowest in dispensing functions. However, as a result of 
inadequacies detected in clinical skills, according to 
participants, the pharmacist’s impact was minimal in the 
areas of therapeutic drug monitoring, promotion of public 
health, and patient counseling.
The expectations are presented in Table IV. The 
physicians and nurses have high expectations of pharma-
cists as knowledgeable drug therapy experts and expect 
them to apply this knowledge in prescription and drug use 
monitoring.
To offer education and counseling about drugs to pa-
tients and other health providers (97.4%), and to improve 
the skills for a better interprofessional communication 
(96.6%) were the most frequent expectations of physicians 
and nurses, which correspond to their perceived needs.
In addition, they expect pharmacists to optimize 
the prescriptions through recommendations (96.1%) and 
to improve clinical training in drug-related problems 
(95.8%). Similar research findings indicated that physi-
cians want pharmacists to communicate with them. In one 
study, physicians recommended that pharmacists notify 
them first, even before the patient, when possible problems 
with drug dose, allergy, or interactions arise. In another 
study of physicians’ opinions, physicians believed that 
pharmacists were competent and knowledgeable and thus 
should be doing more than just dispensing medications. 
(Ranelli, Biss, 2000).
Statistical differences in both health care settings 
were not found, but for physicians and nurses the results 
were not the same. Both professional groups share the 
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most common expectations about pharmacists, even 
though the need for pharmacists to improve their clinical 
training in drug-related problems is much more frequently 
expected by physicians (95.8%) than nurses (61.4%).
In contrast, nurses (89.1%) believe more than physi-
cians (79.8%) that pharmacists should assume responsi-
bility for pharmacotherapy outcomes. These findings for 
each group of health providers show how they perceive 
their relationship with pharmacists, but in general they 
suggest that physicians and nurses want to interact with 
competent pharmacists, and with pharmacists engaged 
in and responsible for patient care and pharmacotherapy 
outcomes.
The perceptions and expectations identified in this 
study illuminate the perceived status of the pharmacist in 
health care settings in Santiago de Cuba, from the perspec-
tives of other health care providers. A wide range of per-
ceptions, understandings and expectations of pharmacists 
were uncovered in this study so that now we might reflect 
upon and design strategies to advance pharmacists’ role 
in the health care system. Issues associated with profes-
sional functions and responsibilities, pharmaceutical care 
practice, professional attitudes and competence, interpro-
fessional communication, ethics, pharmacy education, and 
commitment were raised, and those issues are intimately 
connected with the social role claimed by the professional 
of pharmacy today.
It would be even more illustrative to make a holistic 
analysis of these relationships through the development of 
a qualitative research design that explores the providers’ 
perceptions by means of open and in-depth interviews 
focused on the meanings of pharmacists’ work for other 
health care professionals. (Dupotey, Ramalho de Oliveira, 
2009).
Pharmacists must demonstrate how important they 
are for patients in terms of improving their clinical out-
comes and quality of life. We believe that this is the only 
way pharmacists will be able to gain the confidence of 
physicians, nurses, and the health system in general. It is 
passed the time for pharmacists to take the challenge that 
society has presented to them, and organize their time to 
undertake clinical and cognitive functions, which means 
working directly with patients and other providers, deliver 
the best possible care, and document and evaluate the care 
provided. This is the only way to obtain social recognition 
and the identity of a health care provider.
CONCLUSIONS
From physicians and nurses’ perspectives, the main 
activities performed by pharmacists are related with drug 
supply management and adverse reactions’ reporting. 
Other clinical functions are perceived in low frequency, 
generally in community pharmacies. Pharmaceutical care 
is rarely provided, and it is even less frequent in hospitals. 
Limitations in interprofessional communication and in 
pharmacists’ integration with the health care team have 
been demonstrated. Although health care providers rec-
ognize the pharmacist as a drug expert and as someone 
who provide counseling on drugs, their expectations are 
still associated with drug education and the use of more 
effective communication techniques. The perception of 
TABLE IV - Professionals’ expectations of pharmacists’ role
Professionals’ expectations of 
pharmacists 
Primary health care Hospital
Phys. (%) Nurs. (%) Total (%) Phys. (%) Nurs. (%) Total (%)
To improve pharmacists’ clinical 
training in drug-related problems
205 (52.8) 183 (47.2) 388 (96.5) 94 (27.4) 249 (72.6) 343 (95.0)
To optimize the prescriptions through 
recommendations
207 (53.6) 179 (46.4) 386 (96.1) 95 (27.4) 252 (72.6) 347 (96.1)
To assume responsibility for 
pharmacotherapy outcomes
166 (50.9) 160 (49.1) 326 (81.1) 83 (25.6) 242 (74.4) 325 (90.0)
To collaborate in solving drug-related 
problems
185 (55.2) 150 (44.8) 335 (83.3) 85 (26.2) 240 (73.8) 325 (90.0)
To offer education and counseling 
about drugs
210 (53.3) 184 (46.7) 394 (98.0) 95 (27.2) 254 (72.8) 349 (97.0)
To improve the skills for 
interprofessional communication
201 (52.3) 183 (47.7) 384 (95.5) 96 (27.2) 257 (72.8) 353 (97.8)
pa= 1.000 Probability calculated according to health care settings; pb= 0.000 Probability calculated according to professional 
qualification
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pharmacists’ roles uncovered in this study is a reflection of 
current changes in the health care systems that are leading 
to a greater involvement of the pharmacist in direct patient 
care. New strategies should be implemented in the health 
care environment of Santiago de Cuba, and we believe that 
the acceptance of pharmaceutical care as the new mandate 
for pharmacists is the right direction.
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